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Abstract
Numerous diseases, recently reported to associate with elevated microvesicle/microparticle (MP) counts,
have also long been known to be characterized by accelerated immune complex (IC) formation. The
goal of this study was to investigate the potential overlap between parameters of protein complexes (e.g.
ICs or avidin-biotin complexes) and MPs, which might perturb detection and/or isolation of MPs. In this
work, after comprehensive characterization of MPs by electron microscopy, atomic force microscopy,
dynamic light scattering analysis and flow cytometry, for the first time we drive attention to the fact that
protein complexes, especially insoluble ICs, overlap in biophysical properties (size, light scattering,
sedimentation) with MPs. This, in turn, affects MP quantification by flow cytometry and purification by
differential centrifugation, especially in diseases in which IC formation is common, including not only
autoimmune diseases, but also hematological disorders, infections and cancer. These data may
necessitate reevaluation of certain published data on patient-derived MPs, and contribute to correct the
clinical laboratory assessment of the presence and biological functions of MPs in health and disease.
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Abstract  
 
Numerous diseases, recently reported to associate with elevated microvesicle/microparticle 
(MP) counts, have also long been known to be characterized by accelerated immune complex 
(IC) formation. The goal of this study was to investigate the potential overlap between 
parameters of protein complexes (e.g. ICs or avidin-biotin complexes) and MPs, which might 
perturb detection and/or isolation of MPs. In this work, after comprehensive characterization 
of MPs by electron microscopy, atomic force microscopy, dynamic light scattering analysis 
and flow cytometry, for the first time we drive attention to the fact that protein complexes, 
especially insoluble ICs, overlap in biophysical properties  (size, light scattering, 
sedimentation) with MPs. This, in turn, affects MP quantification by flow cytometry and 
purification by differential centrifugation, especially in diseases in which IC formation is 
common, including not only autoimmune diseases, but also hematological disorders, 
infections and cancer. These data may necessitate reevaluation of certain published data on 
patient-derived MPs, and contribute to correct the clinical laboratory assessment of the 
presence and biological functions of MPs in health and disease. 
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Introduction 
 
Membrane vesicles are small subcellular structures surrounded by a phospholipid bilayer. 
Their release by various cell types is enhanced during activation and apoptosis1. They 
represent heterogeneous structures, and can be classified into several groups depending on 
their size, antigenic features and mechanism of cellular release1. The two best characterized 
categories include exosomes and microvesicles/microparticles (MPs). Both populations are 
characterized by the exposure of phosphatidylserine, which allows annexin-V (AX) to bind to 
these lipid surfaces1. Exosomes comprise small, 50-100 nm sized structures released upon 
exocytosis of multi-vesicular bodies1. The diameter of MPs, formed by membrane blebbing, is 
described to be 100-1,000 nm2. However, precise definitions of MPs are still lacking1,2. MPs 
are found in various biological fluids including blood plasma3, urine4 and synovial fluid 
(SF)5,6. Numerous flow cytometry (FC) studies using blood plasma have shown correlation of 
MP counts with human cardiovascular7 and autoimmune diseases8, hematologic disorders9 
and cancer10. Of particular interest, autoimmune diseases were reported to be characterized by 
elevated levels of MPs11.  
The assessment of exosomes and MPs is complicated by the presence of further known 
categories of membrane bound subcellular structures such as apoptotic vesicles, exosome-like 
vesicles, membrane particles and ectosomes1. There is a substantial size overlap among the 
above vesicle categories, and the size distribution of a given vesicle preparation may also be 
affected by the method used for their isolation3,12,13. Recently, attempts have been made to 
standardize isolation and detection protocols for membrane vesicles3,14. Up till now no 
systematic study has been carried out concerning MP size distributions in blood plasma and 
SF. 
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In contrast to membrane vesicles, immune complexes (ICs) have been known for a long time, 
and were characterized extensively by immunologists. ICs consist of multivalent antigens and 
antibodies, and are either soluble or insoluble15. Soluble ICs consist of 2-10 macromolecules, 
while insoluble ICs form colloidal precipitates15. In the presence of a given antigen/antibody 
ratio, temperature, ionic strength and pH, soluble ICs lose their solubility. Insoluble IC 
particles are characterized by significant light scattering and visible turbidity15. ICs are well 
documented to have immunoregulatory and immunopathological functions16,17. In our work 
we chose to investigate rheumatoid arthritis (RA) SF samples reported to contain high 
amounts of ICs17. 
In this study we demonstrated overlapping biophysical properties (size, light scattering, 
sedimentation) of protein complexes with MPs. Our observations may have an impact of MP 
assessment in a broad variety of diseases in which IC formation is common17-23.  
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Materials and Methods  
Patients 
Normal human blood plasma was collected from healthy donors (4 females, 1 male, mean age 
± s.d.: 38.2 ± 13.6 years, age range: 25-50 years). Blood plasma was also tested from RA 
patients (9 females, 2 males, mean age ± s.d.: 61.8 ± 11.7 years; age range: 38-76 years) and 
from patients with OA (10 females, mean age ± s.d.: 58.4 ± 14.7 years; age range: 35-75 
years). SF samples from patients with RA (11 females; 1 male, mean age ± s.d.: 56.2 ± 15.4 
years; age range 25-74 years) and OA (10 females; 2 males, mean age ± s.d.: 61.7 ± 6.4 years; 
age range 50-68 years) were included in this study. All RA patients fulfilled the diagnostic 
criteria of the American College of Rheumatology (ACR)24. Patients were treated in the 
Department of Rheumatology, Semmelweis University (Budapest, Hungary), the National 
Institute of Rheumatology and Physiotherapy (Budapest) and at the Department of 
Orthopaedics, University of Szeged (Szeged, Hungary). Plasma and SF were centrifuged at 
250g for 10 minutes and 650g for 20 minutes, respectively, in order to eliminate cells. 
Aliquots of the samples were stored at -20°C until use. During the entire investigation period 
we followed the guidelines and regulations of the Helsinki Declaration in 1975, and the 
experiments were approved by the Hungarian Scientific and Research Ethics 
Committee (TUKEB); all patients signed an informed consent form. 
 
Microparticle isolation 
MPs were isolated from blood plasma and SF. SF samples were digested with 10 U/mL sheep 
testis hyaluronidase (Sigma-Aldrich Co., St. Louis, MO, USA) for 30 minutes at 37°C. 
Platelets, cell debris and larger apoptotic bodies were pelleted for 10 minutes at 3,000g, 
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followed by filtration through a 800 nm filter (Millipore Co., Billerica, MA , USA) by gravity. 
MPs were sedimented as described previously (20,500g, 60 minutes at room temperature 
(RT))25,26.  
 
Isolation of ICs 
ICs were isolated from SF samples of patients with RA. Cell-depleted SFs (2 mL) were 
applied onto anti-human IgG and anti-human IgM agarose columns in 0.01 M sodium 
phosphate buffer containing 0.15 M NaCl, pH=7. After 2 hours incubation at RT, the column 
was washed with 50x volumes of binding buffer. The elution of the bound proteins was 
carried out using 4 M MgCl2 buffer (pH=5.5). Eluted ICs were dialyzed against PBS 
overnight. IC preparations were stained with anti-human IgG-FITC, anti-human IgM-FITC 
(Sigma-Aldrich); and AX-FITC (BD Biosciences, Franklin Lakes, NJ, USA) to exclude the 
presence of MPs.  
 
Generation of protein complexes 
Artificial ICs were generated by mixing antigens with specific antibodies using different 
ratios. Human LF, anti-human LF, OVA and anti-human anti-OVA were purchased from 
Sigma-Aldrich. Mouse IgM was produced by the HFPG-846 hybridoma27, and anti-mouse 
IgM-FITC was purchased from Sigma-Aldrich. Antigens and antibodies were mixed in 50 µL 
PBS using different ratios (from 1:10,000 to 10,000:1). Samples were diluted up to 300 µL in 
PBS and were analyzed by FC, DLS and AFM. To generate biotin-streptavidin complexes, a 
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biotinylated goat anti-mouse IgM antibody (Sigma-Aldrich, 5.5 mg/mL) and streptavidin-PE 
(R&D Systems Inc. Minneapolis, MN, USA, 10 μg/mL) were mixed at different ratios. 
 
Detergent lysis 
Triton X-100, Tween20, sodium dodecyl sulfate and Igepal-CA630 (all from Sigma-Aldrich) 
were used to lyse MPs and to disassembly ICs. A commercially available cell lysis buffer was 
also used (BD Biosciences). Various concentrations of the above detergents were mixed 
thoroughly with samples just before analyzing them by FC and DLS. For TEM analysis, MPs 
were mixed with detergents and samples were centrifuged with 20,500g for 60 minutes. The 
pellets were fixed and embedded for TEM analysis. 
 
Transmission electron microscopy and immune-EM 
Shortly after centrifugation, the supernatants were carefully removed and the pellets were 
fixed at RT for 60 minutes with 4% PFA in 0.01 M PBS. After washing with PBS, the 
preparations were post-fixed in 1% OsO4 (Taab, Aldermaston, Berks, UK) for 30 minutes. 
Following rinsing with distilled water, the pellets were dehydrated in graded ethanol, 
including block-staining with 1% uranyl-acetate in 50% ethanol for 30 minutes, and 
embedded in Taab 812 (Taab). After overnight polymerization at 60 °C and sectioning for 
EM, the ultrathin sections were analyzed with a HITACHI 7100 electron microscope 
equipped by Megaview II (lower resolution, Soft Imaging System, Munster, Germany) digital 
camera. For immune-EM, after removal of the fixative and washing, the pellets were blocked 
with 4% BSA in PBS for 60 minutes at RT and incubated with 1:1,000 dilution of anti-human 
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IgG-HRP or anti-human IgM-HRP, respectively, at 4°C overnight (both from Sigma-Aldrich). 
Following washing steps, 3,3-diaminobenzidine (DAB) (Vector Laboratories, Burlingame, 
CA, USA) was applied as chromogen for visualization of ICs. Prior to osmification and 
embedding procedure, the pellets were washed in distilled water for 5 minutes. EM 
microphotographs were analyzed by using ImageJ software (ImageJ 1.42q Wayne Rasband).  
 
Atomic force microscopy  
Using two-beam interference method with the fourth harmonic of an Nd:YAG laser, gratings 
were fabricated on the surface of polycarbonate layers spin-coated onto Si wafers. Isolated 
MPs from blood plasma and SF were applied to the wafers with laser-structured surfaces. 
Incubation in the solutions lasted for 1 h at 37 °C, and then the wafers were washed three 
times in sterile distilled water on a horizontal shaker and finally allowed to dry overnight at 
RT. Immune complex samples were seeded onto freshly cleaved mica. The surfaces were 
dried under a sterile air-flow cabinet for 30 min, then washed gently with sterile distilled 
water twice and allowed to dry overnight at RT. The AFM investigation of the topography of 
different bio-molecule covered surface structures was performed with tapping mode AFM 
(PSIA, Serial No. XE-100, Santa Clara, CA, USA) applying special TM AFM tips (Type 
NSC15, MikroMasch, Tallinn,  Estonia) with nominal radius of curvature 10 nm, typical force 
constant of 40 N/m and resonant frequency of 325 kHz. Both topography and shaded 
topography images were recorded using XEP1.5 (PSIA) acquisition software. Topography 
images were processed with XEI 1.6 (PSIA) using Sobel Edge Enhancement method. 
 
Dynamic light scattering analysis  
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DLS measurements were performed using an ALV goniometer (ALV, Langen, Germany) 
with a Melles Griot diode-pumped solid-state laser (CVI Melles Griot, Albuquerque, NM, 
USA) at 457.5 nm wavelength (type: 58 BLD 301). The intensity of the scattered light was 
measured at 90° and the autocorrelation function was calculated using an IBM PC-based data 
acquisition system developed in the Institute of Biophysics and Radiation Biology, 
Semmelweis University (Budapest, Hungary). Particle size distributions were determined by 
the maximum entropy method.  The result is the relative contribution of the different sized 
particles to the autocorrelation function. Since the scattered light intensity is strongly 
dependent on the size of the particles, this value does not only show the number of particles of 
a given radius, but also overemphasizes those of larger size. Thus, minor amounts of large 
sized impurities will have a significant contribution. We characterized the distribution using 
this value instead of the relative number of the particles, because particle sizes in 
multicomponent systems are described properly by this function. The radius of the particles 
was calculated using sphere approximation. 
 
Flow cytometry 
Samples were analyzed by using a FACSCalibur flow cytometer (BD Biosciences). The FC 
instrument settings and MP gating were adopted from previous works5,8,28. Microbeads of 
various sizes (4 µm and 400 nm in diameter from Life Technologies, Carlsbad CA, USA; 530 
nm from Spherotech, Lake Forest, IL, USA; 100 nm and 1µm from Sigma-Aldrich) were used 
to select optimal instrument settings and MP gate29. The gate was established using 1 µm 
calibration beads as an upper right corner of the gate. The lower border was determined after 
assessing signal/noise ratios and positive event numbers. The gate was set in a way to exclude 
the highest possible noise, but to detect the highest number of signal events. To reduce 
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background event numbers, samples were diluted in 1:30 with 0.01 µm pore size membrane-
filtered PBS or NaCl (Millipore). We used similarly filtered solutions used subsequently for 
all experiments of this study. Total event counts of MP and IC preparations were determined 
within the MP gate. To identify MPs, AX-FITC, AX-PE, anti-CD41a-FITC, anti-CD42a-
PerCP, anti-CD68-FITC, anti-CD45-PerCP-Cy5.5 and were used (all purchased from BD 
Biosciences). AX staining was carried out in the presence of 2.5 mM Ca(2+). Event numbers 
of equal sample volumes were counted for 30 s. Background fluorescence was compared to 
that of the isotype-control antibody. When detecting AX binding, 5 mM EDTA-containing 
0.09% NaCl solution was used to determine the background fluorescence. Staining of ICs was 
carried out using anti-human IgM-FITC in 1:150 and anti-human IgG-FITC in 1:300 (both 
purchased from Sigma-Aldrich). Positive events were calculated within the MP gate and the 
signal was compared to that of the isotype-control antibody.  
 
Anti-C3 ELISA 
To validate FC results, we performed an anti-C3 ELISA, a standard technique for the 
detection of ICs30. Briefly, anti-human C3 antibodies (Sigma-Aldrich) were coated onto 
polystyrene plates at a concentration of 0.2 μg/well. SF samples were used at 1:100 dilution (a 
concentration selected after preliminary experiments). Next, HRP-conjugated anti-human IgM 
and anti-human IgG (both from Sigma-Aldrich) were used at 1:50,000 and 1:30,000 dilutions, 
respectively. Orto-phenylene-diamine (Sigma-Aldrich) and hydrogen peroxide were added 
and the absorbance was detected at 492 nm.  
 
Fluorescence microscopy 
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The 20,500g pellet was obtained from SF samples of RA and OA patients (n=3 in each 
group). To stain ICs in the pellet, it was diluted in 100μl PBS and mixed with anti-human 
IgM-FITC or anti-human IgG-FITC, in 1:50 dilution. After 20 minutes incubation at RT, 
samples were again centrifuged at 20500g for 60 minutes. The pellet was fixed in 4% PFA 
and applied onto slides. Cover slips were mounted on the slides and were analyzed by a Zeiss 
LSM 510 Meta confocal laser scanning microscope (Carl Zeiss, Jena, Germany). Slides were 
excited with a 488 nm Argon laser, and fluorescence was detected with a 505-570 nm BP 
filter. 
 
Statistical analysis 
 
SPSS software (SPSS Inc. Chicago, IL, USA) was used for statistical analyses. Differences 
between RA and OA samples were analyzed by t-test or Mann-Whitney test. For normality 
testing one sample Kolmogorov–Smirnov test was used. Correlations were analyzed by one-
tailed Spearman’s test. 
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Results 
 
Determination of the sizes of microparticles  
 
We used transmission electron-microscopy (TEM) and atomic force microscopy (AFM) to 
visualize MPs isolated from biological samples. MPs are mostly spherical structures of 
various size and electron density as suggested by the TEM and AFM images (Figures 1A and 
1B). We determined the sizes of MPs analyzing TEM and AFM images using ImageJ 
software. Based on the analysis of 180 vesicles, mean sizes (± s.d.) of blood plasma derived 
MPs were found to be 182 nm ± 92 nm and 181 nm ± 71 nm by TEM and AFM, respectively 
(Figure 1C). Mean diameters of RA SF-derived vesicles were 234 nm ± 91 nm and 201 nm ± 
78 nm as assessed by TEM and AFM images, respectively (Figure 1C). Both TEM and AFM 
have limitations of accuracy in determining MP sizes, as both methods examine non-floating, 
pelleted or solid surface-bound MPs. Therefore next we selected dynamic light scattering 
(DLS), suitable to study particle sizes in suspension. The mean (± s.d.) peak hydrodynamic 
radius of isolated MPs was 88 ± 10 nm (176 ± 20 nm in diameter, n=3) in the case of healthy 
blood plasma, while it was 88 ± 15 nm (176 ± 30 nm in diameter, n=3) in RA SF (Figure 1D). 
However, sizes of isolated MPs may also depend on the applied centrifugation and filtration 
processes. To test if native, platelet-free plasma and cell-free SF contain the same sized 
floating MPs as pellets, we investigated the vesicle/particle size distributions in plasma and 
SF samples by DLS. We found peaks corresponding to MPs at around 80-90 nm (160-180 nm 
in diameter) (Figure 1D). MP peaks were found at slightly smaller sizes in native samples 
than in the pelleted MP preparations (peak diameters were 173 ± 30 nm and 170 ± 44 nm in 
blood plasma and SF samples, respectively, n=3 in each group). Moreover, SF and blood 
plasma also contained smaller particles, which were not present in the isolates. The TEM, 
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AFM and DLS results show concordantly that both in native samples and in isolated MP 
preparations, most MPs were within the size range of 80-400 nm irrespective of the source of 
the biological sample.  
 
Determination of sizes of immune complexes  
 
Next we tested size distributions of various ICs, including artificial and natural ones by using 
AFM and DLS. AFM analysis of lactoferrine (LF)-anti-LF clearly showed irregular particles 
sized between 50 and 250 nm (Figure 2A). Based on the analysis of 180 particles, the mean 
diameter (± s.d.) was found to be 138 nm ± 46 nm (Figure 2B). We also tested ICs by DLS, a 
convenient method for IC size determination15. Total scattered light intensity in IC 
preparations was similar to that of MP preparations (data not shown). LF-anti-LF complex 
(antigen/antibody ratio 1:1) showed peaks at 6 nm, 80 nm, and 1,000 nm radii (12, 160 and 
2,000 nm in diameter). OVA-anti-OVA complexes (1:1) revealed peaks at 3, 90 and 1,000 nm 
radii (6, 180 and 2,000 nm in diameter), while IgM-anti-IgM (1:1) resulted in peaks at 4 and 
45 nm (8 and 90 nm in diameter) (Figure 2C). All three artificial ICs showed peaks below 10 
nm in diameter, presumably corresponding to soluble ICs. The peaks at around 100-200 nm in 
diameter were considered as insoluble ICs overlapping with the sizes of MPs. The peaks 
above 1,000 nm were considered as large IC precipitates. 
We also tested if not only artificial, but also natural (ex vivo) ICs, isolated from RA SFs, 
overlapped in size with MPs. IgG containing ICs showed peaks at 2 nm, 105 nm and above 
1,000 nm (4, 210 and 2,000 nm diameter), while IgM ICs resulted in peaks at 6, 20, 105 and 
1,050 nm (12, 40, 210 and 2,100 in diameter) (Figure 2D). Thus, soluble and insoluble 
fractions as well as precipitates were detected within the isolates of natural ICs.  
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The soluble fraction of ICs was too small to interfere either with MP detection or isolation. 
On the contrary, the insoluble fraction (diameter range: 50-250 nm) overlaps with MP sizes 
(range 80-400 nm). Precipitates do not overlap with MPs as they are usually above 1,000 nm 
in diameter. 
 
Detection of immune complexes by flow cytometry 
 
In order to assess the consequences of shared size distribution and light scattering properties 
of MPs and ICs, we tested whether ICs provided a signal within the commonly used MP gate 
in FC. Within this gate, MPs were clearly detected based on their AX binding and/or their 
cell-surface marker positivity (Figures 3A and 3B). First, artificial ICs were investigated by 
FC (Figure 3C) and resulted in intense signals within the MP gate. When one of the 
components of an IC (anti-mouse IgM) was labeled with FITC, an intense fluorescent signal 
was detected (Figure 3D). This provided further evidence in support that ICs were indeed, 
specifically detectable within the MP gate. IC formation was dependent on the applied 
antigen/antibody ratio, and we obtained typical Heidelberg-histograms showing optimal ratios 
(Figure 3E). We also detected fluorescent signals when testing natural ICs (isolated from RA 
SFs) stained with anti-human IgG or anti-human IgM (Supplemental Figure 1). Our data 
suggest that ICs may be detected by FC and characterized by light scattering properties 
similar to those of MPs.   
 
The presence of ICs affects detection of membrane vesicles by FC  
 
To determine whether the presence of ICs affected the detection of MPs in biological samples 
(in which MPs and ICs are present simultaneously), we first developed a simple method to 
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discriminate between IC- and MP-related events by FC. Different concentrations of 
detergents, including Triton X-100, Tween20, sodium dodecyl sulfate and Igepal-CA630 were 
tested in order to assess the degree of MP lysis or IC disassembly. After the addition of 0.05% 
Triton X-100 to the sample, most of the AX or CD41a positive events disappeared (Figure 
4A). Similar results were obtained for CD68, CD45 and CD42a stainings of MPs (data not 
shown). CD42a staining and AX binding were abolished at nearly the same concentrations of 
the detergents (Supplemental Figure 2). Since anti-CD42a and AX bind to MPs by distinct 
mechanisms, the above observation proves that detergents lysed MPs rather than abrogating 
the binding of antibody/AX. ICs showed significant immunopositivity even after the addition 
of 0.05 % Triton X-100 (Figure 4B, Supplemental Figure 2). The presence of the other 
applied detergents, a standard commercial cell lysis buffer (BD Biosciences) or 3 cycles of 
freezing and thawing also differentiated ICs from MPs (data not shown). To prove that 0.05% 
Triton X-100 indeed lysed MPs, we captured TEM images of control and detergent-treated 
MPs (Figure 4C). After addition of detergent, only membrane fragments but no vesicular 
structures were observed (Figure 4C). Furthermore, using DLS, a marked decrease of the MP 
signal was detected after the addition of 0.05% Triton X-100 (Figure 4D). A remaining peak 
at a smaller size might have corresponded to membrane fragments also seen on TEM (Figure 
4C). The decrease of the IC signal on the DLS plot was minimal after addition of the 
detergent (Supplemental Figure 3). The above experiments suggest that IC- or MP- related 
events can be discriminated using low concentrations of detergent: sensitive events 
correspond to MPs, while insensitive events reflect ICs or other protein complexes.  
To exclude that ICs were bound to MP surfaces, we stained IC containing SF samples with 
anti-human IgG-FITC or anti-human IgM-FITC and AX-PE. Only minimal double staining 
was observed (Figure 4E) indicating that most MPs and ICs were present separately in RA 
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SF. Immune-EM images further confirmed that ICs were present in the space among MPs 
rather than on the surface of vesicles (see below).  
To assess whether the presence of ICs in biological samples affected routine MP enumeration 
by FC, diluted blood plasma and SF samples from RA and OA patients were stained with 
anti-human IgG-FITC and anti-human IgM-FITC. RA and OA plasma samples showed only 
minor positivity for ICs, making it unlikely that ICs affect MP counting in RA or OA blood 
plasma samples. On the contrary, RA SF samples showed extremely high positivity for ICs 
compared to OA samples (Figure 4F). All IgG and IgM events were resistant to 0.05% Triton 
X-100 lysis. In order to validate the system, we also used a conventional anti-C3 ELISA for 
the detection of ICs in SF samples. A strong correlation was found between FC and ELISA 
results regarding IgM ICs (one-tailed Spearman correlation, n=22, rho=0.48, p=0.01), but not 
for IgG ICs (n=22, rho=-0.23, p=0.14) (Supplemental Figure 4). This was probably due to the 
presence of rheumatoid factor (RF), an anti-IgG antibody, in the SF samples. RF may bind to 
the detection antibody in FC, thus, resulting in artificial ICs. 
We tested the extent by which the high level of ICs affected the quantitative assessment of 
MPs in RA and OA SFs. Total event counts of SFs within the MP gate correlated with AX 
positive, IgG- and IgM positive events (Table 1). In OA samples total event counts strongly 
correlated with AX positive but not with IC counts as the latter were absent in OA samples. 
Strikingly, in RA SFs total event counts did not correlate with AX positive MP event counts, 
but showed strong correlation with those of ICs. These data suggest that in RA SFs total event 
counts depended on IC counts rather than on the amount of MPs. Hence, when enumeration of 
MPs is based on total event counts rather than on the detection of AX positive events, FC data 
may lead to false results in samples containing high amounts of ICs. In line with this concept, 
we observed 1.41 fold elevation in the total event counts in RA compared to OA SF samples 
(n=21, p=0.147, t-test after normality testing), while there was only an 1.25 fold increase in 
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the AX positive events (n=21, p=0.359, t-test) (Figure 4F). As a conclusion, in this system 
total event counts overestimated the real MP counts due to the highly elevated IC content.   
Importantly, IC formation may falsify MP detection by FC in systems that ignore the potential 
presence of ICs. We observed that using indirect immune labeling, primary and secondary 
antibodies also form ICs detectable within the MP gate (Supplemental Figure 5A). These 
events could not be diminished by the use of low concentration of detergent (0.05% Triton X-
100, data not shown). We also assessed whether streptavidin-PE and a biotinylated antibody 
could form complexes detectable by FC within the MP gate. As avidin is a homotetramer and 
a biotinylated antibody usually carries 3 to 6 molecules of biotin31, the streptavidin-
biotinylated antibody complexes gave MP-mimicking fluorescent signals at an optimal ratio 
(Supplemental Figure 5A).  
Moreover, antibodies tend to aggregate, and self-aggregation of an antibody may also lead to 
false signals. There are several factors that induce self-aggregation of an antibody including 
protein concentration, temperature, ionic strength, pH and agitation32,33. We investigated the 
effect of agitation: a 30s vortexing of a CD14-PE (BD Biosciences) antibody in either PBS or 
normal blood plasma resulted in the appearance of a new, fluorescent event group at the SSC-
FL1 plot (Supplemental Figure 5B). These events could not be abolished after the addition of 
low concentrations of detergents (0.05% Triton X-100) (Supplemental Figure 5B).  
 
ICs contaminate MP preparations  
 
We have shown that ICs may confound FC detection and enumeration of MPs. The next issue 
we investigated was whether ICs were present in conventionally isolated MP preparations. 
MPs were pelleted at 20,500g for 60 minutes as described earlier25,26. The 20,500g pellets 
were labeled with anti-human IgM-FITC and anti-human IgG-FITC and analyzed by 
 For personal use only. at UNIVERSITAETSSPITAL on November 24, 2010. www.bloodjournal.orgFrom 
19 
 
fluorescence microscopy. A marked difference was observed between OA and RA sample-
derived pellets (Figure 5A). On the basis of our FC data we hypothesized that the fluorescent 
staining in the MP pellet corresponded to ICs. To exclude that MPs were stained by the anti-
human IgM or anti-human IgG antibodies, we conducted immune-TEM analysis. Among the 
clearly recognizable MPs, amorphous structures showed immunopositivity, indicating the 
presence of ICs within the pellet (Figure 5B) The majority of MPs were not stained by the 
antibodies in line with the previous FC analysis  (Figure 4E). Subsequent FC and DLS also 
proved the presence of ICs in the 20,500g pellet, while the 20,500g supernatants contained 
substantially fewer immunopositive events (Figure 5C and 5D). Of note, in the pellets, peaks 
smaller than 50 nm were also detected by DLS likely corresponding to resolubilizing 
insoluble ICs. In summary, these results confirmed that ICs indeed were simultaneously 
sedimented with MPs in the 20,500g pellet.  
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Discussion 
Over the last decades, understanding of the universal formation of membrane vesicles by 
prokaryotic34 and eukaryotic35 cells has challenged the long existing paradigm of intercellular 
communication. The explosion-like rise in the number of publications using predominantly 
flow cytometry platforms to analyze microvesicles/microparticles in patient derived samples 
has raised concerns about the reliability of this technology as it may conceal pitfalls that lead 
to erratic conclusions.  
In this work we addressed basic questions regarding MPs. We were the first to compare three 
different methodologies and analyze the size distributions of human blood plasma and SF-
derived MPs using TEM, AFM and DLS. The three methods resulted in highly concordant 
results concerning the size distribution of a given MP preparation.  However, TEM and AFM 
slightly overestimated mean vesicle sizes compared to DLS. This could be explained by the 
fact that due to sedimentation, the morphology, shape and consequently the size of vesicles in 
the pellet might be altered as compared to MPs floating in biological fluids.  Our analysis of 
blood plasma and SF revealed that most MPs had diameters between 80-400 nm. In native 
MP-containing biological samples we detected peaks similar to those obtained when 
analyzing isolated MPs. However, the isolated (pelleted) MPs were somewhat bigger than 
those in the native samples. This could be due either to the fusion of some vesicles during 
centrifugation or to a higher efficacy to pellet out vesicles of larger size. In native samples, 
peaks smaller than 100 nm were also detected by DLS, likely corresponding to exosomes, 
lipoproteins or smaller protein complexes. The size of LDL diameters is reported to be in 
between 25-27 nm36, HDL particles are around 10 nm in diameter37, while triglyceride-rich 
particles have a diameter around 40-80 nm38. Due to their size range, lipoproteins usually do 
not interfere with MP measurements.  Previous reports documented a mean MP size of 247-
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289 nm without filtration in fresh-frozen plasma13 and a peak diameter for red blood cell 
microvesicles of 179 nm39.  
Analyzing ICs we found shared biophysical properties with MPs. Using DLS and AFM, we 
found that ICs contained a fraction overlapping in size with MPs. FC and DLS analyses 
revealed MPs and ICs were characterized by similar light scattering properties. Concerning 
the size, previous reports described insoluble ICs with 200 and 220 nm radii40,15 overlapping 
with MP size distributions that we determined in our experimental systems. In contrast to 
insoluble ICs, soluble ICs and precipitates do not share biophysical parameters with MPs 
being far below and well above the MP size range, respectively. Of note, it is highly unlikely 
that ICs would also interfere with exosome related studies if exosomes are purified using 
ultracentrifugation followed by a subsequent sucrose density gradient ultracentrifugation: 
exosomes are found at lower densities (1.13-1.19 g/mL)1 compared to immune complexes and 
aggregated IgG (above 1.20 g/mL)41.   
A rapidly growing body of FC data report MP analyses of patient derived samples in a broad 
variety of diseases. We hypothesized that the shared parameters of MPs and ICs might have 
lead to spurious findings in the field. The above findings prompted us to develop a simple 
novel method to discriminate MPs from ICs. Using detergent lysis, our data show that in 
biological samples, in which ICs are abundant, total event counts within the MP gate are 
likely to predict IC rather the real MP content.  
Results, obtained without MP-IC discrimination, should be interpreted cautiously. This is also 
underlined by a previous work in which RA SF MPs were reported to carry IgG, IgM, 
complement components, serum amyloid P (SAP) and C-reactive protein (CRP)42. Without 
AX staining, based only on immunopositivity within the MP gate, the authors reported that in 
MP preparations from RA SF, total event counts, IgG, IgM, C1q, C3, C4, CRP and SAP 
reactivities were elevated compared to control SFs, RA and healthy plasma samples. All the 
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above molecules are either components of or are associated with ICs43,44; therefore this study 
presumably detected and described ICs rather than MPs. In our work we found that in 
biological fluids MPs and insoluble ICs appear as distinct particles.  
Our findings have also broader consequences. Indirect immunolabeling, avidin-biotin 
complexes and the self-aggregation of an antibody may also lead to MP-mimicking signals, 
which are detergent resistant. Of importance, the overlapping parameters of ICs and MPs may 
also affect the purity of isolated MP preparations. Most workgroups apply differential-
centrifugation protocols to prepare MPs. In this study, we show that both artificial and natural 
ICs may contaminate the so-called ’MP pellet’. Consistent with our findings a recent report 
has documented the presence of proteinaceous contamination in urinary microvesicle 
preparations45. Given the well known ability of ICs to provoke robust biological 
responses16,17, functional assays that use MPs isolated by differential centrifugation, may lead 
to misleading results. Therefore for functional assays of MPs, AX or other surface marker 
based affinity isolation is highly recommended46,47.  
Our findings also have relevance to non-rheumatologic diseases such as acute coronary 
syndrome and sickle cell disease in which the presence of circulating ICs is well 
documented48,49, and may cause interference with MP detection.      
Data, presented here, bring attention to the substantial size overlap between MPs and ICs that 
may falsify both detection results and functional assays of MPs. Whether these findings also 
imply that in vivo MPs may penetrate and deposit tissue spaces described previously to be 
accessible for ICs, remains to be answered. 
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Table 1. 
 
 
 
 
Table 1. Correlations of total event counts and AX+/IgG+/IgM+ positive event counts by 
FC. The numbers indicate correlation coefficients obtained from one-tailed Spearman’s 
correlations.   ** p<0.01, ***p<0.001.  
 
 
 
 
 
 
 
AX+ events IgG+ events IgM+ events AX++IgG++IgM+ events 
 
Total event count, RA+OA 
 
 0.634** 
 
0.716*** 
 
0.515** 
 
 0.848*** 
Total event count, OA 
 0.883**    0.383   -0.510 0.867** 
Total event count, RA 
    0.154 
  0.930*** 0.720** 0.748** 
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Figure legends: 
 
Figure 1. Size determination of MPs. (A) TEM images of healthy blood plasma- and RA 
SF-derived, isolated MPs. Original magnification was 50,000x, scale bars represent 500 nm. 
Images were recorded at RT using HITACHI 7100 electron microscope equipped with a 
Megaview II digital camera. (B) Shaded topography AFM images of healthy blood plasma- 
and RA SF-derived, isolated MPs. Scale bars represent 500 nm. Images were captured at RT 
using a PSIA XE-100 AFM with a XEP1.5 acquisition software. The imaging medium was 
air. Topography images were processed with XEI 1.6 software using Sobel Edge 
Enhancement method. (C) MP size distributions, determined on the basis of TEM and AFM 
images of 180-180 MPs, are shown by histograms. For the analysis of particles, ImageJ 
software was used. (D) Analysis of isolated MPs and native biological samples by DLS. The x 
axis is set to logarithmic scale; a(rh) denotes the coefficient of autocorrelation function of the 
scattered electric field. Arrows indicate peaks corresponding to MPs in the native samples. 
DLS experiments were carried out at 21 °C.  
 
Figure 2. Size determination of ICs. (A) Topography (left panel) and shaded topography 
(right panel) AFM images of LF-anti-LF, artificial ICs. Scale bar represents 1 µm on the left 
panel. In the insert, the scale bar represents 200 nm. Scale bar represents 250 nm on the right 
panel. Images were captured at RT using a PSIA XE-100 AFM with a XEP1.5 acquisition 
software. The imaging medium was air. Topography images were processed with XEI 1.6 
software using Sobel Edge Enhancement method. (B) Particle size distribution is shown by 
histogram. For the analysis of particles, ImageJ software was used. (C) DLS analysis of LF-
anti-LF, OVA-anti-OVA, IgM-anti-IgM ICs. Arrows indicate peaks overlapping with MP 
sizes. (D) RA SF ICs were isolated on an anti-IgG and anti-IgM agarose columns and were 
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also analyzed by DLS. Arrows indicate peaks overlapping with MP sizes. The x axis is set to 
logarithmic scale; a(rh) denotes the coefficient of autocorrelation function of the scattered 
electric field. DLS experiments were carried out at 21 °C.  
 
Figure 3. IC detection within the MP gate by FC. (A) Density plots showing PBS 
background and isolated MP preparation. Arrows indicate 1 μm calibration bead, R1 indicates 
the MP gate. (B) AX-PE and CD42a-FITC stained events within the MP gate from normal 
blood plasma. Two distinct populations can be recognized: an AX+/CD42a+ (platelet MPs) 
and an AX+/CD42a– (non-platelet MPs) one. (C) Scatter plots of LF-anti-LF (1:10 ratio) IC 
and OVA-anti-OVA (1:1 ratio) IC. Arrow indicates 1 μm calibration bead, R1 indicates the 
MP gate. (D) Fluorescence intensity plot of mouse IgM-anti-mouse IgM-FITC (1:1) IC. 
Events are shown within the R1 gate. (E) The histograms show the effect of different 
antigen/antibody ratios on LF-anti-LF, OVA-anti-OVA and IgM-anti-mouse IgM-FITC IC 
formation. The y axes represent total event counts within the MP gate.  
 
Figure 4. FC analysis of MP and IC containing samples. (A) MPs from RA SF and OA 
plasma have been stained with AX-FITC or CD41a-FITC, and were subjected to detergent 
lysis by 0.05% Triton X-100. moIgG denotes anti-mouse IgG used for isotype control. (B) 
SFs from OA and RA patients were stained with anti-IgG-FITC or anti-IgM-FITC, and were 
also subjected to detergent lysis by 0.05% Triton X-100. All plots represent events from the 
MP gate. (C) To prove MP lysis, isolated MPs were visualized by TEM before and after lysis. 
Original magnification was 20,000x. Scale bars indicate 400 nm. Images were captured at RT 
using HITACHI 7100 electron microscope equipped with a Megaview II digital camera. (D) 
DLS of MPs before and after addition of detergent. The x axis is set to logarithmic scale; a(rh) 
denotes the coefficient of autocorrelation function of the scattered electric field. Arrow 
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indicates the remaining MP-related signal. Arrowhead indicates the signal of Triton X-100.  
DLS experiments were carried out at 21 °C.  (E) Dot plots of RA SFs stained with AX-PE and 
anti-IgG-FITC or anti-IgM-FITC (n=3 in each group). Events are shown within the R1 gate. 
(F) IgG+, IgM+, total and AX+ event counts within the MP of RA and OA SFs. Horizontal 
lines indicate mean values. The p values were obtained from Mann-Whitney test (n=21).  
 
Figure 5. Co-sedimentation of ICs and MPs. (A) Fluorescent microscopy images of anti-
human IgG-FITC or anti human IgM-FITC-stained 20,500g pellets from RA and OA SFs. 
Images were captured at RT using a Zeiss LSM 510 Meta confocal laser scanning microscope 
equipped with an inverted Axiovert 200M microscope, 63x Plan Apochromat oil immersion 
differential interference contrast objectives (numerical aperture: 1.4). (B) The 20,500g pellet 
from RA SF was analyzed by immune-EM, stained with anti-human IgG-HRP or anti-human 
IgM-HRP. Arrowheads indicate immunopositive structures among MPs. Original 
magnification was 50,000x, scale bar indicates 400 nm. Images were captured at RT using 
HITACHI 7100 electron microscope equipped with a Megaview II digital camera. (C) FC 
analysis revealed that isolated ICs were present in the pellet, and were nearly absent in the 
supernatant (SN). (D) Isolated IgG or IgM ICs from RA SFs were also analyzed by DLS. The 
x axis is set to logarithmic scale; a(rh) denotes the coefficient of autocorrelation function of 
the scattered electric field. DLS experiments were carried out at 21 °C.  
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